Answers are grounded in this paper and cite their sources.
Withania somnifera (Ashwagandha) is a medicinal plant with diverse pharmacological properties; however, the therapeutic application of its bioactive constituents is often limited by poor aqueous solubility and low bioavailability. This study aimed to develop chitosan-based nanoparticles loaded with W. somnifera root extract (Ashwa-Chit NPs) and evaluate their physicochemical characteristics and biological activities in comparison with the corresponding aqueous solution of W. somnifera root extract (Ashwa-Aqua). Ashwa-Chit NPs were prepared by ionic gelation and characterized using zeta potential analysis, transmission electron microscopy (TEM), Fourier-transform infrared spectroscopy (FTIR), and In Vitro release studies. The nanoparticles exhibited spherical morphology with an average particle size of 34.15 ± 6.53 nm and a positive zeta potential of +31.5 mV, indicating favorable colloidal stability. GC–MS analysis identified 44 phytochemical constituents, including fatty acid derivatives, terpenoid-related compounds, oxygenated metabolites, and phenolic constituents. The nanoformulation demonstrated sustained-release behavior under acidic conditions, achieving a cumulative release of 74.9% after 16 h. Biological activity assay revealed notable antioxidant, anti-inflammatory, antimicrobial, and antiproliferative activities for both formulations. Ashwa-Aqua exhibited superior antioxidant activity, the strongest cytotoxic effect against HeLa cells (IC 50 = 18.11 ± 1.4 μg/mL). Highest antimicrobial activity, particularly against Candida albicans . In contrast, Ashwa-Chit NPs produced the greatest suppression of the pro-inflammatory cytokines IL-6 and TNF-α in LPS-stimulated A549 cells, indicating enhanced anti-inflammatory efficacy. Although nanoencapsulation did not improve all biological activities, it preserved the bioactivity of the extract while selectively enhancing its anti-inflammatory performance. These findings demonstrate that W. somnifera root extract possesses multifunctional biological activities and that chitosan-based nanoencapsulation represents a promising strategy for controlled phytochemical delivery and modulation of biological responses. The developed nanoformulation may therefore provide a useful tool for future pharmaceutical and biomedical applications.
No takes yet. Share an insight, caveat, or question.
Toto et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: